Israel’s Edocate has developed an app to help educate Health Care Professionals (HCPs) in the management of patients with chronic conditions (e.g. diabetes). Its virtual patient simulation platform allows HCPs to “learn by doing” and “learn by making mistakes” in … Continue reading →

Researchers from Israel’s Ben-Gurion University and elsewhere have developed “molecular tweezers” to combat antibiotic-resistant bacteria. The tweezers destroy the biofilm that protects the bacteria against the immune system. Bacteria cannot develop resistance to this method of attack. https://americansforbgu.org/bgu-molecular-tweezers-battle-bacteria/ https://www.cell.com/cell-chemical-biology/fulltext/S2451-9456(21)00152-5

Scientists from Israel’s Technion Institute and Ben Gurion University are discovering molecules to fight viruses. They trained a neural network using known treatments and then reversed the process to identify previously untested molecules that bind to and disable virus proteins. … Continue reading →

Israel’s BrainsWay (see here previously) has received US FDA clearance for its 3-minute Theta Burst treatment protocol for Major Depressive Disorder (MDD). Patients demonstrate meaningful reduction in depression scores after the treatment. https://www.brainsway.com/news_events/brainsway-receives-fda-clearance-for-three-minute-theta-burst-treatment-protocol-for-major-depressive-disorder/

Israel’s NeoTX Therapeutics (see here Mar 2020) has had FDA approval to begin Phase 2a human trials of its Naptumomab Estafenatox (NAP) treatment for non-small cell lung cancer. NAP binds bacteria to the tumor while activating tumor specific immune cells. … Continue reading →